Benzinga's Top #PreMarket Gainers

By: Benzinga
Intercept Pharmaceuticals (NASDAQ: ICPT ) shares jumped 119.43% to $159.00 in pre-market trading after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been met. Sangamo Biosciences (NASDAQ: SGMO ) shares gained 13.64% to $15.50 in the pre-market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.